| Primary |
| Pneumonia |
18.4% |
| Abdominal Infection |
10.7% |
| Infection |
8.7% |
| Sepsis |
6.6% |
| Prophylaxis |
5.9% |
| Pyrexia |
5.5% |
| Urinary Tract Infection |
5.3% |
| Cellulitis |
3.9% |
| Parkinson's Disease |
3.7% |
| Psychotic Disorder |
3.7% |
| Product Used For Unknown Indication |
3.6% |
| Bronchopneumonia |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Febrile Neutropenia |
3.0% |
| Liver Abscess |
2.9% |
| Klebsiella Infection |
2.7% |
| Pseudomonas Infection |
2.5% |
| Hypomagnesaemia |
2.1% |
| Immunosuppression |
2.1% |
| Lower Respiratory Tract Infection |
2.1% |
|
| Rash |
11.7% |
| Thrombocytopenia |
11.7% |
| Death |
11.3% |
| Renal Failure Acute |
8.0% |
| Anaphylactic Reaction |
5.6% |
| Drug Ineffective |
4.7% |
| Nephropathy Toxic |
4.2% |
| Pyrexia |
4.2% |
| Tubulointerstitial Nephritis |
4.2% |
| Toxic Skin Eruption |
3.8% |
| Haemolytic Anaemia |
3.3% |
| Hypotension |
3.3% |
| Rash Maculo-papular |
3.3% |
| Stevens-johnson Syndrome |
3.3% |
| Urticaria |
3.3% |
| Cholestasis |
2.8% |
| Drug Interaction |
2.8% |
| Hepatotoxicity |
2.8% |
| Torsade De Pointes |
2.8% |
| Toxic Epidermal Necrolysis |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
43.5% |
| Drug Use For Unknown Indication |
7.1% |
| Pneumonia |
5.8% |
| Abdominal Infection |
5.7% |
| Sepsis |
5.2% |
| Infection |
4.0% |
| Pyrexia |
2.8% |
| Prophylaxis |
2.8% |
| Hypertension |
2.6% |
| Acute Lymphocytic Leukaemia |
2.3% |
| Pseudomonas Infection |
2.3% |
| Bacteraemia |
2.1% |
| Acute Myeloid Leukaemia |
2.1% |
| Pneumonia Aspiration |
2.0% |
| Neutropenic Sepsis |
1.8% |
| Antibiotic Therapy |
1.7% |
| Urinary Tract Infection |
1.7% |
| Immunosuppression |
1.5% |
| Lower Respiratory Tract Infection |
1.5% |
| Pain |
1.5% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
8.9% |
| Renal Failure Acute |
8.1% |
| Thrombocytopenia |
7.7% |
| Renal Failure |
6.8% |
| Stevens-johnson Syndrome |
6.8% |
| Clostridial Infection |
6.4% |
| Death |
6.4% |
| Toxic Epidermal Necrolysis |
6.4% |
| White Blood Cell Count Increased |
5.1% |
| Drug Ineffective |
4.7% |
| Pancytopenia |
4.7% |
| Toxic Skin Eruption |
3.8% |
| Cardiac Arrest |
3.4% |
| Weight Decreased |
3.4% |
| Agranulocytosis |
3.0% |
| Photosensitivity Reaction |
3.0% |
| Pyrexia |
3.0% |
| Renal Impairment |
3.0% |
| Septic Shock |
3.0% |
| Cytolytic Hepatitis |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.5% |
| Drug Use For Unknown Indication |
11.8% |
| Pyrexia |
5.9% |
| Prophylaxis |
5.2% |
| Pain |
5.0% |
| Hypertension |
4.2% |
| Sepsis |
3.9% |
| Acute Myeloid Leukaemia |
3.9% |
| Pneumonia |
3.3% |
| Sarcoma Metastatic |
3.2% |
| Infection Prophylaxis |
3.1% |
| Febrile Neutropenia |
2.6% |
| Diffuse Large B-cell Lymphoma |
2.4% |
| Nausea |
2.4% |
| Infection |
2.3% |
| Electrolyte Substitution Therapy |
1.9% |
| Crohn's Disease |
1.8% |
| Antifungal Prophylaxis |
1.7% |
| Myelodysplastic Syndrome |
1.5% |
| Constipation |
1.5% |
|
| Sepsis |
8.9% |
| Pyrexia |
8.1% |
| Septic Shock |
7.5% |
| Transplant Rejection |
7.5% |
| Vomiting |
6.6% |
| Thrombocytopenia |
6.3% |
| Death |
6.1% |
| Pneumonia |
5.8% |
| Respiratory Failure |
5.8% |
| Mucosal Inflammation |
4.6% |
| Febrile Neutropenia |
4.3% |
| Renal Impairment |
4.3% |
| Neutropenia |
3.7% |
| Renal Failure Acute |
3.7% |
| Renal Failure |
3.5% |
| Drug Ineffective |
3.2% |
| Hypotension |
2.9% |
| Skin Exfoliation |
2.6% |
| Cardiac Arrest |
2.3% |
| Dermatitis Exfoliative |
2.3% |
|
| Interacting |
| Central Nervous System Lymphoma |
8.8% |
| Diverticulitis |
8.8% |
| Evidence Based Treatment |
8.8% |
| Pyrexia |
8.8% |
| Acute Promyelocytic Leukaemia |
5.9% |
| Cardiac Failure Congestive |
5.9% |
| Hypertension |
5.9% |
| Product Used For Unknown Indication |
5.9% |
| Staphylococcal Infection |
5.9% |
| Urethral Cancer |
5.9% |
| Atrial Fibrillation |
2.9% |
| Cardiac Flutter |
2.9% |
| Cerebral Infarction |
2.9% |
| Constipation |
2.9% |
| Crohn's Disease |
2.9% |
| Drug Use For Unknown Indication |
2.9% |
| Dyslipidaemia |
2.9% |
| Epilepsy |
2.9% |
| Febrile Neutropenia |
2.9% |
| Hyperlipidaemia |
2.9% |
|
| Drug Interaction |
23.1% |
| Pyrexia |
15.4% |
| Hypocoagulable State |
7.7% |
| Hypoglycaemia |
7.7% |
| Hypotonia |
7.7% |
| Myositis |
7.7% |
| Nephropathy Toxic |
7.7% |
| Renal Failure Acute |
7.7% |
| Renal Impairment |
7.7% |
| Sepsis |
7.7% |
|
